
Previa Medical analyzes the data of the patients in real time and identifies the complication risks. They also provide forecasting pathology. They use FHIR technology for their solutions. The company's contact modes are by mail and physical address.

Previa Medical analyzes the data of the patients in real time and identifies the complication risks. They also provide forecasting pathology. They use FHIR technology for their solutions. The company's contact modes are by mail and physical address.
Headquarters: Lyon, France
Founded: 2020
Sector: Healthtech / Clinical AI
Core product: PREVIA platform — digital biomarkers to predict in-hospital vital emergencies (sepsis, AKI)
Known funding: Seed round ~€2.1M (Feb 2023) / $2,240,000 total reported
Team size (reported): ~10 employees
In-hospital patient deterioration detection and prediction
2020
Healthtech
€2.1M
Reported seed round of €2.1M in Feb 2023 (third‑party profiles); some profiles list WorldUpstart and Bpifrance among investors.
Multiple non-equity assistance entries listed on third‑party profiles
“WorldUpstart and Bpifrance are listed on third‑party profiles as investors”